Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbetocin versus oxytocin-based regimens for prevention of postpartum hemorrhage after cesarean section
ACTRN12615000546550Phase 3Completed
- Sponsor
- Sherine Hosny Mohamed
- Start
- Jun 2015
- Modality
- Peptides, Recombinant Proteins and Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in postpartum hemorrhage (PPH) comparing Carbetocin, Oxytocin bolus plus infusion and Misoprostol plus oxytocin (3 arms). Primary endpoints: Incidence of major obstetric hemorrhage, Need for additional uterotonic agent and 1 more. Started Jun 2015; status: completed.
02
Drugs
carbetocinoxytocinmisoprostol
03
Conditions
postpartum hemorrhage (PPH)
Beyond the preview
Go deeper on ACTRN12615000546550.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12615000546550.